Immediate Management of Acute Sepsis in Hospitalized Patients
For patients admitted with suspected acute sepsis, immediately stabilize airway, breathing, and circulation while simultaneously obtaining blood cultures and initiating broad-spectrum intravenous antibiotics within one hour of recognition, followed by aggressive fluid resuscitation with crystalloids.
Initial Assessment and Risk Stratification (First 15 Minutes)
Vital Signs and Severity Scoring
- Calculate a NEWS2 (National Early Warning Score) immediately upon hospital arrival 1
- Document Glasgow Coma Scale (GCS) for both prognostic value and monitoring deterioration 1
- High risk criteria: NEWS2 score ≥7 requires urgent assessment by a team with critical care competencies 1
- Moderate risk: NEWS2 score 5-6 or score of 3 in any single physiological parameter requires urgent clinician review 1
- Consider qSOFA or SOFA scores to determine risk of severe illness or death from sepsis 2
Critical Decision Points Within First Hour
- Senior clinician review and ICU admission decision must occur within the first hour 1
- Do not be falsely reassured by lower early warning scores—septic patients can deteriorate rapidly 1
Diagnostic Testing Protocol (Within First Hour)
Mandatory Immediate Tests
- Blood cultures: Obtain two sets as soon as possible and always within 1 hour of hospital arrival, before antibiotics if this causes no delay >45 minutes 1, 2, 3
- Lactate level: Essential for assessing tissue hypoperfusion and monitoring resuscitation endpoints (target <2 mmol/L) 1
- Complete blood count with differential 3
- Comprehensive metabolic panel including renal and liver function 2
- Coagulation studies (PT/INR, PTT, platelet count) to assess for sepsis-induced coagulopathy 3
Additional Diagnostic Studies
- Procalcitonin (PCT): Rises within 4 hours of bacterial exposure with levels ≥1.5 ng/ml showing 100% sensitivity and 72% specificity for sepsis in ICU populations 3
- C-Reactive Protein (CRP): Levels ≥50 mg/L demonstrate 98.5% sensitivity and 75% specificity for probable or definite sepsis 3
- Site-specific cultures: Urine, sputum, wound cultures, or other relevant specimens based on suspected source 2, 4
- Imaging studies: Chest X-ray, urinary tract imaging, or other studies to identify infection source and complications 2
Antibiotic Administration Protocol
Timing Based on Risk Stratification
- High risk (NEWS2 ≥7 or septic shock): Administer IV antibiotics within 1 hour of recognition 1, 2, 3, 4, 5, 6
- Moderate risk (NEWS2 5-6): Administer within 3 hours 1
- Low risk (NEWS2 <5): Administer within 6 hours 1
Critical caveat: Every 30-minute delay in antibiotic administration for septic shock significantly increases mortality—do not delay beyond one hour for high-risk patients 2, 5
Empiric Antibiotic Selection
- Use broad-spectrum agents active against all likely bacterial and fungal pathogens with good penetration to the presumed infection source 4, 5, 6, 7
- For urosepsis: Amoxicillin plus aminoglycoside, second-generation cephalosporin plus aminoglycoside, or IV third-generation cephalosporin 2
- Avoid fluoroquinolones if local resistance rates ≥10% or patient used them in last 6 months 2
- Consider combination therapy for Pseudomonas infections and neutropenic patients 4, 6
- Implement loading doses for all patients, then individualize subsequent dosing based on pharmacokinetics/pharmacodynamics and organ dysfunction 5
Fluid Resuscitation and Hemodynamic Management
Initial Fluid Bolus
- Administer 500 ml crystalloid bolus rapidly (over 5-10 minutes) for patients with signs of shock or severe sepsis 1
- Give at least 30 ml/kg IV crystalloid within first 3 hours for sepsis-induced hypoperfusion 2, 3
- Monitor carefully for fluid overload with repeated clinical assessment 1
Resuscitation Endpoints
Target the following parameters 1:
- Mean arterial pressure ≥65 mmHg 2, 3
- Capillary refill time <2 seconds 1
- Warm extremities with normal pulses (no differential between peripheral and central) 1
- Urine output >0.5 ml/kg/hour (requires urinary catheter) 1, 2
- Normal mental status 1
- Central venous pressure 8-12 mmHg 1
- Lactate <2 mmol/L 1
Vasopressor Support
- Initiate vasopressors in critical care setting if shock does not respond to initial fluid challenges 1
- Target mean arterial pressure of at least 65 mmHg 2, 3
Source Control
Urgent Interventions
- Identify anatomic source of infection requiring source control as rapidly as possible 2, 3
- Address urinary tract obstruction or anatomical abnormality within 12 hours of diagnosis 2, 3
- Remove or replace indwelling urinary catheters before starting antimicrobials 2
- Use the least invasive approach for source control 2
Ongoing Monitoring and Re-evaluation
Frequency of Reassessment
- High risk patients: Re-calculate NEWS2 and re-evaluate every 30 minutes 1
- Moderate risk patients: Re-evaluate every hour 1
- Low risk patients: Re-evaluate every 4-6 hours 1
Daily Antimicrobial Stewardship
- Reassess antimicrobial therapy daily for potential de-escalation based on culture results and clinical response 2, 4, 5, 6, 7
- De-escalate to narrower spectrum antibiotics within 1 hour of receiving microbiological results 1
- Discontinue combination therapy after 3-5 days once susceptibilities available 4, 6
- Typical duration is 7-10 days; consider shorter courses (5-7 days) with rapid clinical resolution and effective source control 2, 4, 6
- Stop antibiotics if infection is not the etiologic factor for shock 4, 6
Common Pitfalls to Avoid
- Never delay antibiotics beyond one hour for high-risk patients or those with septic shock—mortality increases significantly with each delay 2, 5
- Do not skip blood cultures before antibiotics unless this causes substantial delay (>45 minutes) 2, 3
- Avoid inadequate source control, particularly in obstructive uropathy or abscess formation 2
- Do not use empiric fluoroquinolones in areas with high resistance rates or recent patient exposure 2
- Never give false reassurance from low early warning scores—septic patients deteriorate rapidly and require frequent reassessment 1
- Avoid fluid overload by giving crystalloids in 500 ml boluses with careful monitoring rather than large single volumes 1